NOD2 Promotes Glioblastoma Progression Through Effects on Epithelial–Mesenchymal Transition and Cancer Stemness

<b>Background</b>: Glioblastoma multiforme (GBM) represents one of the most aggressive and lethal primary brain malignancies, characterized by rapid proliferation, extensive invasiveness, and a dismal prognosis. Emerging evidence implicates nucleotide-binding oligomerization domain-containing protein 2 (<i>NOD2</i>), an intracellular pattern recognition receptor, as a potential driver of GBM progression. This study investigates NOD2's role in promoting glioblastoma through its effects on the epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) markers. <b>Methods</b>: NOD2 expression levels and survival outcomes were assessed using TCGA data from GBM tumor samples (<i>n</i> = 153) and normal brain tissues (<i>n</i> = 5). NOD2 protein expression was validated in glioma cell lines using Western blot and immunofluorescence analyses. Functional studies employed siRNA-mediated <i>NOD2</i> knockdown to evaluate effects on cellular proliferation, migration, invasion, and colony formation, while correlations between NOD2 and EMT/CSC markers were assessed. <b>Results</b>: The analysis of TCGA data revealed a significantly elevated <i>NOD2</i> expression in GBM tumors compared to normal brain tissue, with a high <i>NOD2</i> expression correlating with a reduced disease-free survival in GBM patients. All tested glioma cell lines demonstrated robust NOD2 expression. Functional analyses demonstrated that NOD2 depletion substantially impaired cellular proliferation, migration, invasion, and the colony-forming capacity. Mechanistically, siRNA-mediated <i>NOD2</i> knockdown significantly decreased the expression of EMT (Snail, SLUG, Vimentin) and CSC markers (CD44, CD133) at both protein and mRNA levels. <b>Conclusions</b>: Our results indicate that NOD2 contributes to GBM progression by influencing EMT and CSC pathways. These findings suggest NOD2's potential as a therapeutic target in glioblastoma, highlighting the need for further mechanistic studies and therapeutic exploration.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2025-08-21
DOI
https://doi.org/10.3390/biomedicines13082041
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

NOD2 Promotes Glioblastoma Progression Through Effects on Epithelial–Mesenchymal Transition and Cancer Stemness

Ji Young Lee, Sung Sun Kim, Shubhash Chandra Chaudhary, S M Abdus Salam et al.
Biomedicines
Cancer-related molecular mechanisms research
article

NOD2 Promotes Glioblastoma Progression Through Effects on Epithelial–Mesenchymal Transition and Cancer Stemness

Ji Young Lee, Sung Sun Kim, Shubhash Chandra Chaudhary, S M Abdus Salam, Nah Ihm Kim, Eun‐Jung Ahn, Kyung‐Sub Moon, Eshrat Jahan, Kyung‐Hwa Lee, Jong‐Hwan Park, Tae-Young Jung
article en

Abstract

<b>Background</b>: Glioblastoma multiforme (GBM) represents one of the most aggressive and lethal primary brain malignancies, characterized by rapid proliferation, extensive invasiveness, and a dismal prognosis. Emerging evidence implicates nucleotide-binding oligomerization domain-containing protein 2 (<i>NOD2</i>), an intracellular pattern recognition receptor, as a potential driver of GBM progression. This study investigates NOD2's role in promoting glioblastoma through its effects on the epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) markers. <b>Methods</b>: NOD2 expression levels and survival outcomes were assessed using TCGA data from GBM tumor samples (<i>n</i> = 153) and normal brain tissues (<i>n</i> = 5). NOD2 protein expression was validated in glioma cell lines using Western blot and immunofluorescence analyses. Functional studies employed siRNA-mediated <i>NOD2</i> knockdown to evaluate effects on cellular proliferation, migration, invasion, and colony formation, while correlations between NOD2 and EMT/CSC markers were assessed. <b>Results</b>: The analysis of TCGA data revealed a significantly elevated <i>NOD2</i> expression in GBM tumors compared to normal brain tissue, with a high <i>NOD2</i> expression correlating with a reduced disease-free survival in GBM patients. All tested glioma cell lines demonstrated robust NOD2 expression. Functional analyses demonstrated that NOD2 depletion substantially impaired cellular proliferation, migration, invasion, and the colony-forming capacity. Mechanistically, siRNA-mediated <i>NOD2</i> knockdown significantly decreased the expression of EMT (Snail, SLUG, Vimentin) and CSC markers (CD44, CD133) at both protein and mRNA levels. <b>Conclusions</b>: Our results indicate that NOD2 contributes to GBM progression by influencing EMT and CSC pathways. These findings suggest NOD2's potential as a therapeutic target in glioblastoma, highlighting the need for further mechanistic studies and therapeutic exploration.

BiomedicinesVol. 13(8)
Chonnam National University (KR), Chonnam National University Hwasun Hospital (KR)
Openalex Percentile: Top 73%
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.